Shanghai Registry of Acute Coronary Events

• Status: Terminated
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: All

Summary

SRACE is an multicenter observational database of outcomes for patients who are hospitalized with an acute coronary events. SRACE includes over 20 hospitals in Shanghai China that have enrolled a total of more than 3,000 patients since 2005, with an annual enrollment of 500 patients. The major purpose of the SRACE program is to evaluate the prognosis of patients admitted to the hospital due to acute coronary events, comparing different therapeutic strategies, in-hospital transferring system, and so on. All participating physicians receive confidential quarterly reports showing ther outcomes side-by-side with the aggregate outcomes of all participating hospitals.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Shanghai Jiao Tong University School of Medicine
• Collaborators: Changhai Hospital; Ministry of Science and Technology of the People´s Republic of China
• Treatments: Tirofiban

Criteria

Inclusion Criteria:

• patients admitted to the hospital with acute coronary syndrome and received medical or interventional treatment

Exclusion Criteria:

• non ACS patients;

• complicated with other lethal disease

• predicted life span less than 12 months

• known allergy history to any anti-platelet or anti-thrombin medicine

• unconscious at the time of arrival at the hospital